...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Biogen
5
Dec 02, 2019 06:58PM
1
Dec 02, 2019 08:47PM
2
Dec 02, 2019 09:33PM
4
Dec 02, 2019 10:00PM

ImmunoSupremo - I think a big plus for ABL is the length of time patients were on the drug durring BETonMACE, 6 to 36 months. Safe for cronic use I think were the words used. If we get an increase in cognitve function I think it will be a first historically. If that's the case it should at least raise a few eyebrows.

tada

4
Dec 03, 2019 07:46AM
10
Dec 03, 2019 10:37AM
Share
New Message
Please login to post a reply